Fundraising Fox

Laurence Rulleau

Investor

Managing Partner at CTI Life Sciences Fund L.P.

Montreal, Canada

About

Laurence Rulleau, a PhD-trained biologist and former life sciences equity analyst, uniquely originates and builds companies around assets, having led creation of Dalcor, Ilkos, Precithera, Find Therapeutics and Epitopea.

Contact· self-published, not guessed

Invests in

BiotechHealthtechMedical Devices

Experience

  1. Domain TherapeuticsChairwoman of the Boardcurrent2022 — present
  2. EpitopeaChairwoman of the Boardcurrent2021 — present
  3. CTI Life Sciences FundManaging Partner at CTI LSF IIIcurrent2020 — present
  4. CTI Life Sciences FundPartner at CTI LSF II2014 — 2020Montreal, Quebec, Canada
  5. Find TherapeuticsBoard Membercurrent2020 — presentMontreal, Quebec, Canada
  6. DalCor PharmaceuticalsMember Board Of Directorscurrent2016 — presentGreater Montreal Metropolitan Area
  7. adMare BioInnovationsBOD member2019 — 2025Vancouver, British Columbia, Canada
  8. ILKOS THERAPEUTICS Inc.Board Observer2017 — 2020Greater Montreal Metropolitan Area
  9. PreciThera, Inc.BOD member2017 — 2020Montreal, Quebec, Canada
  10. CDRDBOD Member2018 — 2019Vancouver, British Columbia, Canada
  11. Visterra Inc.Board Observer2017 — 2019Greater Boston
  12. NEOMED InstituteChair Of The Board Of Directors2017 — 2019Greater Montreal Metropolitan Area
  13. NEOMED InstituteMember of the Board of Directors2015 — 2019Greater Montreal Metropolitan Area
  14. Societe de Gestion Centre d'excellence en thérapie cellulaireMember of Board of Directors2012 — 2017Greater Montreal Metropolitan Area
  15. Gestion UnivalorVice-President Business Development2011 — 2014Greater Montreal Metropolitan Area
  16. Merieux developpementVenture Partner2010 — 2011
  17. HLA-G TechnologiesCEO2008 — 2010
  18. Blackmont CapitalBiotechnology analyst2006 — 2008
  19. Orion securitiesBiotechnology analyst2005 — 2006
  20. Desjardins securitiesVice-President biotechnology2003 — 2006
  21. YORKTON SECURITIES INCBiotechnology analyst2000 — 2003
  22. Banque Laurentienne securitiesBiotechnology analyst1998 — 2000

Skills & more

Strategy5Biotechnology39Venture Capital18Lifesciences25Pharmaceutical Industry24Technology Transfer8Commercialization10Biopharmaceuticals2Business Development14Drug Discovery4Entrepreneurship5Drug Development8
+11 moreStart-upsClinical DevelopmentBiotechnologieSciences de la vieTransfert technologiqueCapital risqueCommercialisationStratégieBusiness StrategyLicensingClinical Trials

Languages English · french

From Laurence's professional profile.

Colleagues at CTI Life Sciences Fund L.P.

Dana Matzen
Partner at CTI Life Sciences Fund L.P.
Ken Pastor
Managing Partner at CTI Life Sciences Fund L.P.
Paul Cassar
Associate at CTI Life Sciences Fund L.P.
Radhika Gupta
Principal at CTI Life Sciences Fund L.P.
Shermaine Tiley
Managing Partner at CTI Life Sciences Fund L.P.
Shermaine Tilley
Managing Partner at CTI Life Sciences Fund L.P.
Xin Hang
Principal at CTI Life Sciences Fund L.P.
Youssef Bennani
Managing Partner at CTI Life Sciences Fund L.P.

Frequently asked questions

Who is Laurence Rulleau?
Laurence Rulleau, a PhD-trained biologist and former life sciences equity analyst, uniquely originates and builds companies around assets, having led creation of Dalcor, Ilkos, Precithera, Find Therapeutics and Epitopea.
Where does Laurence Rulleau work?
Laurence Rulleau is Managing Partner at CTI Life Sciences Fund L.P..
What does Laurence Rulleau invest in?
Laurence Rulleau invests in Biotech, Healthtech, Medical Devices.
Where did Laurence Rulleau go to school?
Laurence Rulleau studied at UQAM | Université du Québec à Montréal (Master, viro-immunology); Université de Montréal (PhD, Molecular biology).

Same school

Also attended UQAM | Université du Québec à Montréal38

Sasha LuccioniInvestor at Blue Tulip VenturesGreg PetersonManaging Director at Hercules Capital, Inc.Emily HaniotisPrincipal, Investments at DiagramErnestAdvisor at Triptyq CapitalAssmae LoudyiSenior Vice President, Montréal at Allied Properties REITJonathan FairManaging Partner at MedStartr Ventures

+ 32 more

Also attended Université de Montréal72

Anne-Sophie GauvinCommunications & Office Manager at Luge CapitalJyri EngeströmPartner at Lifeline VenturesRajaa GrarVenture Partner at Springdale VenturesErich SieberFounding General Partner at PeakBridge VCFrancois GrattonInvestor at AgeTech CapitalSasha LuccioniInvestor at Blue Tulip Ventures

+ 66 more

Shared employers

Also worked at Domain Therapeutics1

Roberto De PontiSenior Advisor at Claris Ventures

Also worked at DalCor Pharmaceuticals1

John GlasspoolVenture Partner at Agent Capital

Also worked at adMare BioInnovations7

Danielle KarakasAnalyst at Lumira VenturesNancy HarrisonVenture Partner at Amplitude Venture CapitalPatricia EscoffierPrincipal at Seido CapitalPatrick BradleyManaging Director at Station12Barry GeeDirector, Public Affairs at Toronto Innovation Acceleration PartnersDavid ShinDirector, Research & Investments at DRI Healthcare

+ 1 more

Also worked at PreciThera, Inc.1

Pierre BeauparlantPh.D. – Executive Managing Director at Finchley Healthcare Ventures